Hopkins Lupus Cohort. 1999 update.
The Hopkins Lupus Cohort is a decade-long prospective study, now numbering 800 patients with systemic lupus erythematosus. In this article, predictors of disease activity, disease damage (including accelerated atherosclerosis and antiphospholipid antibody syndrome) and health status are reviewed.
Petri
M
M
Hopkins Lupus Cohort, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. mpetri@welchlink.welch.jhu.edu
D000328:Adult; D000368:Aged; D016736:Antiphospholipid Syndrome / Q000209:etiology*; D001161:Arteriosclerosis / Q000209:etiology*; D015331:Cohort Studies; D018450:Disease Progression; D005260:Female; D006304:Health Status; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis